Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Fund moves › McCormick & Company › Lawrence E. Kurzius disclosed a 11.8% stake in MKC and may seek to inf Fund moves
Why it stands out A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Date of the event that required the filing Jan 13, 2026
Reporting period Not applicable
Filed with the SEC Jan 15, 2026 activist 5% holder
Context Change vs prior quarter Undefined
Compared with the manager's prior 13F
Tracked managers with the same change NaN
For the same quarter
0001193125-26-014165
Data quality Verified: identifiers matched exactly
Around the same time Insider filing
Traded Feb 12 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Insider selling
Traded Feb 12 · filed 1 day later Not reported under a pre-arranged trading plan
A major shareholder of McCormick sold $3.58M of McCormick shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Feb 12 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Oct 23, 2024 Congress Disclosed purchase of MKC — reported range $1,001 - $15,000 Nov 12, 2025 Insider · First sale since 2022 CEO sold ~$3.75M of MKC shares in the open market Jan 13, 2026 Insider · 6 days before an 8-K 10% owner sold ~$3.37M of MKC shares in the open market What came next Jan 15, 2026 5% stake Lawrence E. Kurzius filed an activist stake (13D) of 11.8% Jan 19, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On January 19, 2026, Maritza G. Montiel informed the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of McCormick & Company, Incorporated (the “Registrant”) that she intends to retire from the Board of the Registrant and will not stand for election at the Registrant’s next annual stockholders’ meeting, which is currently scheduled for April 1, 2026.” Jan 22, 2026 Company filing · Form 8-K · Results Reported its results Feb 2, 2026 Congress Disclosed sale of MKC — reported range $1,001 - $15,000 Feb 3, 2026 Insider Director sold ~$319K of MKC shares in the open market Feb 5, 2026 Insider Director sold ~$335K of MKC shares in the open market Feb 9, 2026 Insider Director sold ~$340K of MKC shares in the open market Feb 12, 2026 Insider 10% owner sold ~$3.58M of MKC shares in the open market Feb 13, 2026 5% stake Brendan M. Foley filed an activist stake (13D) of 5.1% Mar 12, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On March 12, 2026, Gregory P. Repas, Vice President & Controller, provided notice of his intention to retire from McCormick & Company, Incorporated (the “Company”), effective July 1, 2026.” Mar 27, 2026 5% stake The Vanguard Group reported a passive stake (13G) Mar 31, 2026 Company filing · Form 8-K · Results Reported its results Mar 31, 2026 Company filing · Form 8-K · Material agreement, Reg FD Signed an important agreement, and shared information with investors Mar 31, 2026 Company filing · Form 8-K · Material agreement Signed an important agreement Apr 10, 2026 Insider · 5 days before an 8-K Director purchased ~$106K of MKC shares in the open market Apr 15, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On April 15, 2026, McCormick & Company, Incorporated (the “Company”), announced that Andrew Foust, President Americas, has been appointed to the role of Chief Integration Officer to lead the integration related to the Company’s recently announced combination with the foods business of Unilever PLC (the “Transaction”).” Apr 28, 2026 Company filing · Form 8-K · Material agreement, New debt Signed an important agreement, and took on new debt or obligations (and 1 more item) Apr 29, 2026 5% stake Vanguard Portfolio Management reported a passive stake (13G) of 5.5% Apr 30, 2026 5% stake Vanguard Capital Management reported a passive stake (13G) of 7.5%